Teladoc Health, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US87918A1051
USD
5.57
0.09 (1.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Azenta, Inc.
The Ensign Group, Inc.
Amedisys, Inc.
Encompass Health Corp.
Option Care Health, Inc.
Teladoc Health, Inc.
Acadia Healthcare Co., Inc.
Agilon Health, Inc.
Ginkgo Bioworks Holdings, Inc.
Guardant Health, Inc.
DaVita, Inc.

Why is Teladoc Health, Inc. ?

1
Flat results in Jun 25
  • DEBTORS TURNOVER RATIO(HY) Lowest at 10.96 times
2
Risky - Negative Operating Profits
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -27.98%, its profits have risen by 27.3%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -27.98% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Teladoc Health, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Teladoc Health, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Teladoc Health, Inc.
-36.85%
-0.47
60.23%
S&P 500
13.68%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
23.86%
EBIT Growth (5y)
-256.85%
EBIT to Interest (avg)
-13.59
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
0.82
Tax Ratio
1.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
98.19%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.69
EV to EBIT
-6.94
EV to EBITDA
6.51
EV to Capital Employed
0.74
EV to Sales
0.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-10.69%
ROE (Latest)
-9.12%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET PROFIT(HY)

Higher at USD -57.31 MM

INTEREST COVERAGE RATIO(Q)

Highest at 1,252.67

OPERATING PROFIT(Q)

Highest at USD 56.7 MM

OPERATING PROFIT MARGIN(Q)

Highest at 9.05 %

-2What is not working for the Company
CASH AND EQV(HY)

Lowest at USD 1,405.87 MM

NET SALES(Q)

Lowest at USD 626.44 MM

Here's what is working for Teladoc Health, Inc.

Interest Coverage Ratio
Highest at 1,252.67
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Profit
Higher at USD -57.31 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Profit
Highest at USD 56.7 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 9.05 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Here's what is not working for Teladoc Health, Inc.

Net Sales
Lowest at USD 626.44 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (USD MM)

Cash and Eqv
Lowest at USD 1,405.87 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents